Chromosome 4q31 locus in COPD is also associated with lung cancer

Chronic obstructive pulmonary disease (COPD) is the single greatest risk factor for lung cancer in smokers and is found in 50–90% of lung cancer cases. The link between COPD and lung cancer may stem in part from the matrix remodelling and repair processes underlying COPD, and the development of epithelial–mesenchymal transition (EMT) that underlies lung carcinogenesis. The Hedgehog-interacting protein (HHIP), which mediates the epithelial response (EMT) to smoking, has been implicated in COPD and lung cancer. Recent genome-wide and candidate gene studies of COPD implicate genetic variants on the chromosomal 4q31 (HHIP/glycophorin A (GYPA)) locus. In a case–control study of smokers with normal lung function, COPD and lung cancer (subphenotyped for COPD), we show the GG genotype of the rs 1489759 HHIP single-nucleotide polymorphism (SNP) and the CC genotype of the rs 2202507 GYPA SNP confers a “protective” effect on COPD (OR 0.59, p = 0.006 for HHIP and OR = 0.65, p = 0.006 for GYPA) and lung cancer (OR = 0.70 (p = 0.05) for HHIP and OR 0.70 (p = 0.02) for GYPA). This study suggests that, in smokers, genetic variants of the 4q31 locus conferring a protective effect for COPD are also protective in lung cancer. We conclude that genetic susceptibility to lung cancer includes COPD-related gene variants.

[1]  Hidetoshi Nakamura.  Genetics of COPD. , 2011, Allergology international : official journal of the Japanese Society of Allergology.

[2]  Inês Barroso,et al.  Genome-wide association study identifies five loci associated with lung function , 2010, Nature Genetics.

[3]  M. Fine,et al.  Diagnosis of pulmonary malignancy after hospitalization for pneumonia. , 2011, The American journal of medicine.

[4]  Marc Decramer,et al.  The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. , 2010, American journal of respiratory and critical care medicine.

[5]  J. Cunningham,et al.  A Rigorous and Comprehensive Validation: Common Genetic Variations and Lung Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[6]  David B. Goldstein,et al.  Rare Variants Create Synthetic Genome-Wide Associations , 2010, PLoS biology.

[7]  A. Hofman,et al.  Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function , 2010, Nature Genetics.

[8]  A. Hofman,et al.  Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study , 2009, European Respiratory Journal.

[9]  R. Hopkins,et al.  Pharmacological actions of statins: potential utility in COPD , 2009, European Respiratory Review.

[10]  W. Cardoso,et al.  Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease. , 2009, Proceedings of the American Thoracic Society.

[11]  G. Gamble,et al.  A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers , 2009, Postgraduate Medical Journal.

[12]  M. Spitz,et al.  Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. , 2009, Cancer research.

[13]  Gina Lee,et al.  Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer , 2009, Current opinion in pulmonary medicine.

[14]  D. Mannino,et al.  The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. , 2009, American journal of respiratory and critical care medicine.

[15]  J. Thompson,et al.  Choosing between per-genotype, per-allele, and trend approaches for initial detection of gene–disease association , 2009 .

[16]  G. Gamble,et al.  Lung Cancer Susceptibility Model Based on Age, Family History and Genetic Variants , 2009, PloS one.

[17]  K. Shianna,et al.  A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.

[18]  Scott T. Weiss,et al.  A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study , 2009, PLoS genetics.

[19]  P. Metcalf,et al.  COPD prevalence is increased in lung cancer, independent of age, sex and smoking history , 2009, European Respiratory Journal.

[20]  R. Wood‐Baker,et al.  Smoking has potential to initiate basement membrane disruption and epithelial mesenchymal transition in COPD , 2009 .

[21]  G. Gamble,et al.  Lung cancer gene associated with COPD: triple whammy or possible confounding effect? , 2008, European Respiratory Journal.

[22]  J. Leader,et al.  Association of radiographic emphysema and airflow obstruction with lung cancer. , 2008, American journal of respiratory and critical care medicine.

[23]  G. Eichele,et al.  Sleep apnoea: time to consider clock genes , 2008, European Respiratory Journal.

[24]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[25]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[26]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[27]  T. Manolio,et al.  How to Interpret a Genome-wide Association Study Topic Collections , 2022 .

[28]  W. Malorni,et al.  Radical generation and alterations of erythrocyte integrity as bioindicators of diagnostic or prognostic value in COPD? , 2008, Antioxidants & redox signaling.

[29]  Y. Shintani,et al.  Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. , 2008, American journal of respiratory cell and molecular biology.

[30]  Gorka Bastarrika,et al.  Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. , 2007, Chest.

[31]  M. Raz,et al.  Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel. , 2007, The Israel Medical Association journal : IMAJ.

[32]  C. Amos.  Successful design and conduct of genome-wide association studies. , 2007, Human molecular genetics.

[33]  R. Hopkins,et al.  Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes , 2007, European Respiratory Journal.

[34]  G. O'Connor,et al.  Framingham Heart Study genome-wide association: results for pulmonary function measures , 2007, BMC Medical Genetics.

[35]  T. Frayling.  Genome–wide association studies provide new insights into type 2 diabetes aetiology , 2007, Nature Reviews Genetics.

[36]  M. Gallup,et al.  Wnt and Hedgehog Are Critical Mediators of Cigarette Smoke-Induced Lung Cancer , 2006, PloS one.

[37]  J Vestbo,et al.  Developing COPD: a 25 year follow up study of the general population , 2006, Thorax.

[38]  Z. Tümer,et al.  Hedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitro. , 2006, Lung cancer.

[39]  J. Lü,et al.  Regulation of early lung morphogenesis: questions, facts and controversies , 2006, Development.

[40]  M. Gallup,et al.  Epithelial-mesenchymal transition in lung cancer: is tobacco the "smoking gun"? , 2006, American journal of respiratory cell and molecular biology.

[41]  A. Schwartz,et al.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[42]  N. Craddock,et al.  Design of Case‐controls Studies with Unscreened Controls , 2005, Annals of human genetics.

[43]  S. Thibodeau,et al.  Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. , 2005, Chest.

[44]  D. Mannino,et al.  Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. , 2003, Archives of internal medicine.

[45]  Stephen B. Baylin,et al.  Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer , 2003, Nature.

[46]  A. McMahon,et al.  Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. , 2003, Genes & development.

[47]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[48]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[49]  Pao-Tien Chuang,et al.  Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein , 1999, Nature.

[50]  E. Piitulainen,et al.  Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). , 1999, The European respiratory journal.

[51]  S. Redline,et al.  Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. , 1989, American journal of epidemiology.

[52]  N. Anthonisen,et al.  Airways obstruction and the risk for lung cancer. , 1987, Annals of internal medicine.

[53]  E. Pollack,et al.  What are the odds that smoking will kill you? , 1987, American journal of public health.

[54]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.